TUESDAY, July 13, 2021 (HealthDay News) — Breathing in protection: Scientists say an experimental inhaled COVID-19 vaccine shows promise in animal tests. “The currently available vaccines against COVID-19 are very successful, but the majority of the world’s population is still unvaccinated and there is a critical need for more vaccinesContinue Reading

FRIDAY, July 9, 2021 (HealthDay News) — Why do some people infected with SARS-CoV-2 have either no or negligible symptoms, while others sicken and die? Scientists who’ve pinpointed several genetic markers associated with severe COVID-19 say their findings could provide answers to that important question — and targets for futureContinue Reading

FRIDAY, July 9, 2021 (HealthDay News) — A double dose of China’s CoronaVac vaccine is 83.5% effective against symptomatic COVID-19, researchers say. Their phase 3 trial included more than 10,000 people, aged 18 to 59, in Turkey who received either two doses of CoronaVac 14 days apart or an inactiveContinue Reading

THURSDAY, July 8, 2021 (HealthDay News) — Researchers have identified specific brain circuitry that is related to people’s sense of spirituality — and it’s centered in a brain region linked to pain inhibition, altruism and unconditional love. The findings add to research seeking to understand the biological basis for humanContinue Reading

WEDNESDAY, July 7, 2021 (HealthDay News) — A quick daily “workout” for the breathing muscles may help people lower their blood pressure to a similar degree as exercise or even medication, a small study suggests. The technique is called inspiratory muscle strength training (IMST), and it involves using a deviceContinue Reading

WEDNESDAY, July 7, 2021 (HealthDay News) — A quick daily “workout” for the breathing muscles may help people lower their blood pressure to a similar degree as exercise or even medication, a small study suggests. The technique is called inspiratory muscle strength training (IMST), and it involves using a deviceContinue Reading

THURSDAY, July 1, 2021 (HealthDay News) — An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found — raising hopes that it could become the first medication for the serious digestive disorder. With celiac disease, the immune system attacks the lining of the smallContinue Reading